Crinetics Pharmaceuticals Inc (CRNX)
56.82
+0.13
(+0.23%)
USD |
NASDAQ |
Nov 04, 16:00
56.82
0.00 (0.00%)
After-Hours: 20:00
Crinetics Pharmaceuticals Total Assets (Quarterly): 935.54M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 935.54M |
March 31, 2024 | 978.15M |
December 31, 2023 | 635.35M |
September 30, 2023 | 641.54M |
June 30, 2023 | 293.25M |
March 31, 2023 | 314.01M |
December 31, 2022 | 352.18M |
September 30, 2022 | 384.88M |
June 30, 2022 | 421.73M |
March 31, 2022 | 333.29M |
December 31, 2021 | 351.02M |
September 30, 2021 | 209.36M |
June 30, 2021 | 216.93M |
March 31, 2021 | 163.55M |
Date | Value |
---|---|
December 31, 2020 | 183.44M |
September 30, 2020 | 200.32M |
June 30, 2020 | 217.12M |
March 31, 2020 | 123.88M |
December 31, 2019 | 130.38M |
September 30, 2019 | 142.51M |
June 30, 2019 | 155.15M |
March 31, 2019 | 166.76M |
December 31, 2018 | 171.42M |
September 30, 2018 | 176.68M |
June 30, 2018 | 74.70M |
March 31, 2018 | 76.33M |
December 31, 2017 | 15.60M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
123.88M
Minimum
Mar 2020
978.15M
Maximum
Mar 2024
372.94M
Average
314.01M
Median
Mar 2023
Total Assets (Quarterly) Benchmarks
PTC Therapeutics Inc | 1.916B |
Zevra Therapeutics Inc | 144.41M |
Clearside Biomedical Inc | 33.93M |
Biomea Fusion Inc | 110.42M |
NovaBay Pharmaceuticals Inc | 3.925M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 104.77M |
Shareholders Equity (Quarterly) | 830.76M |
Current Ratio | 16.09 |